New Monoclonal Antibodies to Gardnerella Vaginalis

ViroStat releases a set of new monoclonal antibodies to Gardnerella vaginalis

Written byViroStat
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00

Gardnerella vaginalis is a major species present in bacterial vaginosis. It is a small gram variable, anaerobic coccobacillus. Overgrowth of this bacterium occurs due to an imbalance of normal vaginal flora which can result from prescription antibiotics.

Monoclonal Antibodies to Gardnerella vaginalisMonoclonal Antibodies to Gardnerella vaginalis.Credit: ViroStatMicroscopic evaluation often shows this bacterium associated with epithelial “clue cells”. Treatment with metronidazole or clindamycin is recommended.

ViroStat has just released a set of new monoclonal antibodies to Gardnerella vaginalis. These specific antibodies do not cross react with other agents including Chlamydia, Candida albicans, and Neisseria gonorrhoeae. Several of the antibodies function as pairs in ELISA and lateral flow immunoassay for antigen detection.

Download data sheets for these antibodies at www.virostat-inc.com.

ViroStat is a primary manufacturer, supplying infectious disease reagents to researchers and rapid test manufacturers since 1985.

Contact ViroStat for your free copy of the new catalog at 207-856-6620 or view and download it online at www.virostat-inc.com.

Add Lab Manager as a preferred source on Google

Add Lab Manager as a preferred Google source to see more of our trusted coverage.

Related Topics

Loading Next Article...
Loading Next Article...

CURRENT ISSUE - January/February 2026

How to Build Trust Into Every Lab Result

Applying the Six Cs Helps Labs Deliver Results Stakeholders Can Rely On

Lab Manager January/February 2026 Cover Image